alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
ex4_1.htm








EXHIBIT 4.1








	


	
ROSS MILLER


Secretary of State


204 North Carson Street, Suite 1


Carson City, Nevada 89701-4520


(775) 684 5708


Website: www.nvsos.gov













	
 


Amendment to


Certificate of Designation


After Issuance of Class or Series


(PURSUANT TO NRS 78.1955)


 

	  











	
USE BLACK INK ONLY - DO NOT HIGHLIGHT

	
ABOVE SPACE IS FOR OFFICE USE ONLY












Certificate of Amendment to Certificate of Designation For


Nevada Profit Corporations


(Pursuant to NRS 78.1955-After issuance of Class or Series)







1.  Name of corporation:







NANOVIRICIDES, INC.







2.  Stockholder approval pursuant to statute has been obtained.







3.  The class or series of stock being amended: SERIES B CONVERTIBLE PREFERRED STOCK


.


4.  By a resolution adopted by the board of directors, the certificate of designation is being amended as follows or the new class or series is:







6.           Conversion.







(a)          Commencing on the date of execution of this Certificate of Designation and every fourteenth (14th) day thereafter (or, if such day is not a Trading Day, then the first day thereafter that is a Trading Day) (each, a “Conversion Date”), 40,000 shares of Series B Preferred Stock (or such lesser number of Shares that remains unconverted (or such other number as may be agreed upon by the Purchaser and the Company in amounts of 5,000 shares) shall be automatically converted into shares of Common Stock, of the Company, subject to the conditions to conversion set forth herein and in accordance with Section 6(c) below.







5.  Effective date of filing: (optional)


(must not be later than 90 days after the certificate is filed)






  





  











  








6.   Signature: (required)


 



	
X /s/ Anil R. Diwan,

	  





Signature of Officer


 


Filing Fee: $175.00


 


IMPORTANT: Failure to include any of the above information and submit with the proper fees may cause this filing to be rejected.


 



	
This form must be accompanied by appropriate fees.

	
Nevada Secretary of State Stock Designation


Revised: 3-6-09
AEGIS SEF | 2829 Technology Forest Boulevard, Suite 440 | The Woodlands, Texas 77381

Chapter 1503

Aluminum Fixed Swap - LME Aluminum CMA Swap (LBS) - LME

DESCRIPTION

A monthly cash settled swap based upon the price published by LME for the location specified in 

Floating Price A.

FLOATING PRICE A

The Floating Price for each contract month is equal to the arithmetic average of the LME Official Cash 

Settlement Price for Primary Aluminum for each business day that it is determined during the contract 

month.

CONTRACT UNIT AND VALUE

The contract quantity shall be pounds. Each contract based shall be valued as the contract quantity in 

pounds multiplied by the settlement price.

LISTING CYCLE

Up to 120 consecutive monthly contract periods.

PRICING AND FLUCTUATIONS

Prices shall be quoted in U.S. dollars per pound. The minimum price fluctuation shall be $0.001 

per pound. The minimum price increment will be $0.0001. There shall be no maximum price 

fluctuation.

TERMINATION OF TRADING

Posting of transactions shall cease on the last calendar day of the contract month.

FINAL SETTLEMENT

Delivery under the contract shall be by cash settlement. Final settlement, following termination 

of posting for a contract month, will be based on the Floating Price. The final settlement price 

will be the Floating Price calculated for each contract month.
**EXHIBIT
31.2**
 
 **Certification
of Chief Executive Officer and Chief Financial Officer pursuant to Section 302**
 **of
the Sarbanes-Oxley Act of 2002**
 
 I, Robert
Rankin, certify that:
 
 1.
    I
      have reviewed this annual report on Form 10-KSB of SMALL WORLD KIDS, INC.;
 
 2.
    Based
      on my knowledge, this report does not contain any untrue statement of a
      material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      report;
 
 3.
    Based
      on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this report;
 
 4.
    The
      registrant’s other certifying officer(s) and I are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
      and have:
 
 a)
    Designed
      such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under our supervision, to ensure
      that material information relating to the registrant, including its
      consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this report is being
      prepared;
 
 b)
    Evaluated
      the effectiveness of the registrant’s disclosure controls and procedures
      and presented in this report our conclusions about the effectiveness of
      the disclosure controls and procedures, as of the end of the period
      covered by this report based on such evaluation; and
 
 c)
    Disclosed
      in this report any change in the registrant’s internal control over
      financial reporting that occurred during the registrant’s most recent
      fiscal quarter that has materially affected, or is reasonably likely to
      materially affect, the registrant’s internal control over financial
      reporting; and
 
 5.
    The
      registrant’s other certifying officer(s) and I have disclosed, based on
      our most recent evaluation of internal control over financial reporting,
      to the registrant’s auditors and the audit committee of the registrant’s
      board of directors (or persons performing the equivalent functions):
 
 a)
    All
      significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the registrant’s ability to record,
      process, summarize and report financial information; and
 
 b)
    Any
      fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant’s internal control
      over financial reporting.
 
 ****Date: March 24, 2005
    By:
    /s/ Robert
RankinName: Robert RankinTitle:
      Chief Financial Officer
EXHIBIT
32.2








CERTIFICATION
OF CHIEF FINANCIAL OFFICER PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




















In connection
with the Quarterly Report of First Guaranty Bancshares, Inc. (the “Company”) on
Form 10-Q as of and for the quarter ended March 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Michele
E. LoBianco, Chief Financial Officer of the Company, certify that to the best of
my knowledge:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and


(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.
































/s/ Michele E.
LoBianco


Michele
E. LoBianco


Chief
Financial Officer


Secretary
and Treasurer


May 15,
2009
**Exhibit
      32.1**




**Certification
      of Chief Executive Officer and Chief Financial Officer**


**Pursuant
      to 18 U.S.C. Section 1350,**


**as
      Adopted Pursuant to**


**Section
      906 of the Sarbanes-Oxley Act of 2002**




In
      connection with the Quarterly Report of Pax Biofuels Inc. (the “Company”) on
      Form 10-QSB for the period ending July 31, 2007 as filed with the Securities
      and
      Exchange Commission on the date hereof (the “Report”), I, Paul Leslie Hammond,
      Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as
      adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:




(1)
            The
                Report fully complies with the requirements of section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934;
                and




(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and result of operations of the
                Company.






IN
      WITNESS WHEREOF, the undersigned has executed this certification as of
      the 3rdday of
      December 2007.




/s/
      Paul
      Leslie Hammond


Principal
      Executive Officer, Financial Officer


and
      Accounting Officer
Exhibit 32.1


          CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the filing of Amendment No. 1 to the Quarterly Report on Form
10-QSB/A for the quarterly period ended June 30, 2006 (the "Report") by
CapSource Financial, Inc. ("Registrant"), I, Fred C. Boethling, certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350, that to the best of my knowledge:


1.   The Report fully complies with the requirements of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934, as amended, and

2.   The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of Registrant.

     A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to CapSource
Financial, Inc. and will be retained by CapSource Financial, Inc. and furnished
to the Securities and Exchange Commission or its staff upon request.



     DATE:  January 17, 2007             By: /s/ Fred C. Boethling
                                             -------------------------
                                         Name: Fred C. Boethling
                                         Chief Executive Officer
July 28, 2015

Jeffrey D. Kyle, Clerk

Third Court of Appeals

P.O. Box 12547

Austin, Texas 78711-2457

VIA E-MAIL: 3rdclerksandreporters@txcourts.gov

Re: Court of Appeals No. 03-15-00446-CV

 Trial Court Cause No. D-1-GN-10-000772

Style: In re: Voda Petroleum State Superfund Site Litigation

Dear Mr. Kyle,

I was notified yesterday, July 27, 2015, requesting the record for the above-referenced matter. I 

have sent an invoice to transcribe the record to the appellant. Once I receive payment, I will 

notify the Third Court of Appeals. 

If you need any further information or have any questions, please do not hesitate to call or e-mail 

me at alicia.racanelli@traviscountytx.gov.

Very truly yours,

/s/ Alicia Racanelli

Alicia Racanelli

Official Court Reporter

Alicia Racanelli, CSR

Official Court Reporter

201st Judicial District Court

Room 327

1000 Guadalupe Street

Austin, Texas 78701

Phone: (512) 854-4028

Fax: (512) 854-2268
---

EXHIBIT 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO18 U.S.C. SECTION 1350,AS
ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Theron Resource
Group (the Company) on Form 10-Q for the second quarter ended November 30,
2009, as filed with the Securities and Exchange Commission on the date hereof
(the Periodic Report), I, Jerry R. Satchwell, Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

|1. | the Periodic Report fully complies with the requirements
      of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
    and                                 
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                          
|2. | the information contained in the Periodic Report fairly
      presents, in all material respects, the financial condition and results of
      operations of the Company.

Date: January 14, 2010

/s/ Jerry R. Satchwell

Jerry R. Satchwell Chief
Financial Officer

---
#### Jonathan LOVE, Plaintiff-Appellant, v. Robert MEKEMSON; et al., Defendants-Appellees.

No. 08-16506.

United States Court of Appeals, Ninth Circuit.

Submitted Sept. 13, 2010.*

Filed Oct. 6, 2010.

Jonathan Love, Susanville, CA, pro se.

Before: SILVERMAN, CALLAHAN, and N.R. SMITH, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Jonathan Love, a California state prisoner, appeals pro se from the district court’s judgment dismissing under 28 U.S.C. § 1915A his 42 U.S.C. § 1983 action alleging deliberate indifference to medical needs. We have jurisdiction under 28 U.S.C. § 1291. We review de novo. *Resnick v. Hayes,*213 F.3d 443, 447 (9th Cir.2000). We affirm.

The district court properly dismissed Love’s deliberate indifference claims because the allegations set forth in his *210amended complaint and the attachments thereto state, at most, a claim for negligence. *See Toguchi v. Chung,*391 F.3d 1051, 1060 (9th Cir.2004) (“A showing of medical malpractice or negligence is insufficient to establish a constitutional deprivation under the Eighth Amendment.”). Moreover, a difference in opinion between Love and the prison physicians about the preferred course of medical treatment does not constitute an Eighth Amendment violation. *See id.*at 1058.

Love’s remaining contentions are unpersuasive.

AFFIRMED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by 9 th Cir. R. 36-3.
Order entered January 22, 2020

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-18-00985-CV

ALAA MOHAMAD WEISS, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the County Criminal Court of Appeals No. 2

Dallas County, Texas

Trial Court Cause No. M0474358

ORDER

Before the Court is the State’s January 16, 2020 second motion to extend time to file its 

brief. We GRANT the motion and ORDER the brief be filed no later than February 18, 2020. 

We caution the State that further extension requests will be disfavored.

/s/ ERIN A. NOWELL 

JUSTICE
EXHIBIT 12

ST. JUDE MEDICAL, INC.

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(in thousands)



Nine Months Ended
        
        FISCAL YEARSeptember 27, 2008
        
        2007
        
        2006
        
        2005
        
        2004
        
        2003EARNINGSEarnings before income taxes
        
        $
        823,304
        
        $
        744,305
        
        $
        720,641
        
        $
        621,404
        
        $
        537,192
        
        $
        458,637Plus fixed charges:Interest expense (1)
        
        
        15,238
        
        
        38,229
        
        
        33,883
        
        
        10,028
        
        
        4,810
        
        
        3,746Rent interest factor (2)
        
        
        6,858
        
        
        9,144
        
        
        8,190
        
        
        7,659
        
        
        5,778
        
        
        5,513TOTAL FIXED CHARGES
        
        
        22,096
        
        
        47,373
        
        
        42,073
        
        
        17,687
        
        
        10,588
        
        
        9,259EARNINGS BEFORE INCOME TAXES AND FIXED CHARGES
        
        $
        845,400
        
        $
        791,678
        
        $
        762,714
        
        $
        639,091
        
        $
        547,780
        
        $
        467,896RATIO OF EARNINGS TO FIXED CHARGES
        
        
        38.3
        
        
        16.7
        
        
        18.1
        
        
        36.1
        
        
        51.7
        
        
        50.5






(1)
        Interest expense consists of interest on indebtedness and amortization of debt issuance costs.




(2)
        Approximately one-third of rental expense is deemed representative of the interest factor.




---
Exhibit 31.2


CERTIFICATION





I, Craig Stout, certify that:





1. I have reviewed this quarterly report on Form 10-Q of IMedicor, Inc.;





2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;





3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;





4. The small business issuer's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:





a.  designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;





b.  evaluated the effectiveness of the registrant’s disclosure controls and procedures as of the end of the period (the “Evaluation Date”); and





c.   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;





5. The small business issuer's other certifying officer and I have disclosed, based on our most recent evaluation, of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):





a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and





b. any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.





6.  The registrant’s other certifying officer and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.





IMedicor, Inc.

(Registrant)Date: November 19, 2010
By:
/s/ Craig StoutCraig StoutChief Financial Officer(Principal Accounting Officer)
Exhibit 13.1



CERTIFICATION

PURSUANT TO 18 USC. SECTION 1350,

AS ADOPTED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



I, John Condron, as Chief Executive Officer of Yell Finance B.V. and Yellow
Pages Limited (the Companies), hereby certify, pursuant to 18 U.S.C. § 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:



|(1) |  | the accompanying Annual Report on Form 20-F for the period ending March 31, 2004, as filed with the U.S. Securities and Exchange Commission (the Report) fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|--- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(2) |  | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Companies.
|--- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------



|    |  |                                     
|--- |  | ------------------------------------
|    | 
|    |  | YELL FINANCE B.V.                   
|    | 
|By: |  | /s/    JOHN
CONDRON                 
|    |  | John Condron Chief Executive Officer
|    | 
|    |  | YELLOW PAGES LIMITED                
|    | 
|By: |  | /s/    JOHN
CONDRON                 
|    |  | John Condron Chief Executive Officer



Date: June 8, 2004



NB: A signed original of this written
statement required by Section 906 has been provided to Yell Finance B.V. and will be retained by Yell Finance B.V. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.1

CERTIFICATION

In connection with the periodic report of Abraxis BioScience, Inc. (the
Company) on Form 10-Q for the quarterly period ended September 30, 2008 as filed with the Securities and Exchange Commission (the Report), I, Patrick Soon-Shiong, Chief Executive Officer of the Company, hereby
certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
| | --- | -------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods
indicated.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: November 14, 2008



/s/ PATRICK SOON-SHIONG, M.D.Patrick Soon-Shiong, M.D.Chief Executive Officer


This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act). Such certification
will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.